Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

Cell

Volumn 89, Issue 5, 1997, Pages 765-771

  Otto, Florian ^a,f   Thornell, Anders P ^a,g   Crompton, Tessa ^a   Denzel, Angela ^a   Gilmour, Kimberly C ^a   Rosewell, Ian R ^a   Stamp, Gordon W H ^b   Beddington, Rosa S P ^c   Mundlos, Stefan ^d,h   Olsen, Bjorn R ^d   Selby, Paul B ^e   Owen, Michael J ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

^e OAK RIDGE NATIONAL LABORATORY   (United States)

^f UNIVERSITY OF FREIBURG   (Germany)

^g CMB   (Sweden)

^h JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; GENE LOCUS; GENE MUTATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SKELETON;

ANIMALIA;

EID: 0030666372     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80259-7     Document Type: Article

References (19)

1. Banerjee, C., Hiebert, S.W., Stein, J.L., Lian, J.B., and Stein, G.S. (1996). An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc. Natl. Acad. Sci. USA 93, 4968-4973.
2. Beddington, R.S.P., Morgernstern, J., Land, H., and Hogan, A. (1989). An in situ transgenic enzyme marker for the midgestation mouse embryo and the visualization of inner cell mass clones during early organogenesis. Development 106, 37-46.
3. Ducy, P., and Karsenty, G. (1995). Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15, 1858-1869.
4. Erlebacher, A., Filvaroff, E.H., Gitelman, S.E., and Derynck, R. (1995). Toward a molecular understanding of skeletal development. Cell 80, 371-378.
5. Geoffroy, V., Ducy, P., and Karsenty, G. (1995). A PEBP2 alpha/AML-1 related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J. Biol. Chem. 270, 30973-30979.
6. Hamvas, R., Trachtulec, Z., Forejt, J., Williams, R.W., Arzt, K., Fischer-Lindahl, K., and Silver, L.M. (1996). Encyclopedia of the mouse genome V. Mouse chromosome 17. Mammalian Genome 6, S281-S299.
7. Ito, Y. (1996). Structural alterations in the transcription factors PEBP2/CBF linked to four different types of leukemia. J. Cancer Res. Clin. Oncol. 122, 266-274.
8. Kaufman, M.H., ed. (1992). The Atlas of Mouse Development (San Diego, California: Academic Press), pp. 495-506.
9. Levanon, D., Negreanu, V., Bernstein, Y., Bar-Am, I., Avivi, L., and Groner, Y. (1994). AML1, AML2 and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23, 425-432.
10. Malik, D.Y., and Damon, M.E. (1982). Development of alkaline phosphatase to give a less soluble red end-product. J. Clin. Pathol. 35, 1092-1094.
11. Mundlos, S., Mulliken, J.B., Abramson, D.L., Warman, M.L., Knoll, J.H., and Olsen, B.R. (1995). Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family. Hum. Mol. Genet. 4, 71-75.
12. Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G., and Downing, J.R. (1996). AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330.
13. Ramesar, R.S., Greenberg, J., Martin, R., Goliath, R., Bardien, S., Mundlos, S., and Beighton, P. (1996). Mapping of the gene for cleidocranial dysplasia in the historical Cape Town (Arnold) kindred and evidence for locus homogeneity. J. Med. Genet. 33, 511-514.
14. Sasaki, K., Yagi, H., Bronson, R.T., Tominaga, K., Matsunashi, T., Deguchi, K., Tani, Y., Kishimoto, T., and Komori, T. (1996). Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor β. Proc. Natl. Acad. Sci. USA 93, 12359-12363.
15. Selby, P.B., and Selby, P.R. (1978). Gamma-ray-induced dominant mutations that cause skeletal abnormalities in mice: II. Description of proved mutations. Mut. Res. 51, 199-236.
16. Sillence, D.O., Ritchie, H.E., and Selby, P.B. (1987). Animal model: skeletal anomalies in mice with cleidocranial dysplasia. Am. J. Med. Genet. 27, 75-85.
17. Speck, N.A., and Terryl, S. (1995). A new transcription factor family associated with human leukemias. Crit. Rev. Eukaryot. Gene Expr. 5, 337-364.
18. Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A.H., and Speck, N.A. (1996a). Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93, 3444-3449.
19. Wang, Q., Stacy, T., Miller, J.D., Lewis, A.F., Gu, T.-L., Huang, X., Bushweller, J.H., Bories, J.-C., Alt, F.W., Ryan, G., et al. (1996b). The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell 87, 697-708.